Hutch News

Hutch News

Stories tagged 'cord blood transplant'

Scientists-turned-entrepreneurs share lessons learned launching startups

From venture capital to office space to acquisitions, academics starting companies face a steep learning curve — but there’s help to be found

Nov. 13, 2017 | By Rachel Tompa / Fred Hutch News Service

Scientists who make the leap from academia to founding their own companies face a steep learning curve. There's a lot to learn and a lot to take in. But help is available.

View story >


Bezos family gives $35 million to Fred Hutch

‘What we are really giving is the gift of time’; funds will be invested in more world-class faculty to speed cures for cancer patients

March 30, 2017 | By Linda Dahlstrom / Fred Hutch News Service

The single, largest gift to Fred Hutchinson Cancer Research Center will be invested in hiring more world-class faculty to speed cures for cancer patients, said President and Director Dr. Gary Gilliland.

View story >


Big support for the littlest patients

Fred Hutch Holiday Gala brings in more than $13 million to grow pediatric cancer research and develop needed therapies for children

Dec. 5, 2016 | By Diane Mapes / Fred Hutch News Service

The Hutch Holiday Gala, the single largest fundraiser for Fred Hutchinson Cancer Research Center, raised more than $13 million to expand pediatric cancer research and develop new therapies for children. Read about the Saturday evening soiree here.

View story >


The cost of survival

Treatment complications can impact lives for years after cure but some cancers survivors are reluctant to reveal their pain

Nov. 4, 2016 | By Bill Briggs / Fred Hutch News Service

Some survivors say it’s hard for those untouched by cancer to understand the scales of life don’t always balance with survival on one side and a jumble of complications heaped on the other.

View story >


For high-risk leukemia patients, umbilical cord blood transplant associated with lower risk of relapse

Study compares ‘alternative’ donor source vs. traditional transplantation of blood stem cells from an adult, unrelated donor

Sept. 7, 2016 | By Rachel Tompa / Fred Hutch News Service

A new study by Fred Hutch researchers, published today in The New England Journal of Medicine, has found that umbilical cord blood transplants may have advantages beyond being an alternative source of stem cells for patients without a traditional donor match. They also are associated with a lower risk of relapse in high-risk leukemia patients.

View story >


‘I want this to be something everyone can get’

New Fred Hutch spinoff to commercialize cord blood stem cell therapies based on work by Drs. Colleen Delaney, Irwin Bernstein

Dec. 3, 2015 | By Susan Keown / Fred Hutch News Service

A new Fred Hutch spinoff, Nohla Therapeutics, will commercialize cord blood stem cell therapies based on work by Dr. Colleen Delaney and Dr. Irwin Bernstein. In preliminary studies, the company’s first product helps stem cells engraft more quickly after transplant and protects patients from deadly infections during this vulnerable period.

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.